EMCURE PHARMACEUTICALS
Back to Income Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹35.96 | ₹27.50 | ₹29.42 | ₹36.62 | ₹21.68 |
What is the latest Earnings Per Share (EPS) of EMCURE PHARMACEUTICALS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹35.96 |
| Mar2025 | ₹27.50 |
| Mar2024 | ₹29.42 |
| Mar2023 | ₹36.62 |
| Mar2022 | ₹21.68 |
How is Earnings Per Share (EPS) of EMCURE PHARMACEUTICALS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹35.96 | 30.76 | |
| Mar2025 | ₹27.50 | -6.53 | |
| Mar2024 | ₹29.42 | -19.66 | |
| Mar2023 | ₹36.62 | 68.91 | |
| Mar2022 | ₹21.68 | - | |
Compare Earnings Per Share (EPS) of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹41,251.2 Cr | 16.7% | 12.2% | 48% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,122.0 Cr | 0.7% | -0.3% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹266,424.0 Cr | 4% | 8.9% | 54.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,914.0 Cr | 3.6% | -0.5% | 28.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,599.0 Cr | 2.5% | 13.6% | 9.4% | Stock Analytics | |
| CIPLA | ₹113,112.0 Cr | 3.2% | 5% | -11.9% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 16.7% |
12.2% |
48% |
| SENSEX | 5.5% |
7.5% |
-8.7% |
You may also like the below Video Courses